FDA Approves Genentech’s Cotellic™ in Combination With Zelboraf®; FORUM Announces Removal of Partial Clinical Hold on Phase 3 Encenicline Program Print E-mail
By Josh Gee   
Wednesday, 11 November 2015 20:07
Below is a look at some of the headlines for companies that made news in the healthcare sector on November 11, 2015.     
Read more...
 
MediciNova Receives Notice of Allowance for New Patent Covering MN-221; FDA Grants TEVA Therapy Designation for SD-809 Print E-mail
By Mary Davila   
Tuesday, 10 November 2015 19:42
Below is a look at some of the headlines for companies that made news in the healthcare sector on November 10, 2015.     
Read more...
 
Capricor Presents Positive Data from the DYNAMIC Clinical Trial; Collegium Announces FDA Tentative Approval for Xtampza(TM) ER Print E-mail
By Josh Gee   
Monday, 09 November 2015 19:40
Below is a look at some of the headlines for companies that made news in the healthcare sector on November 9, 2015.      
Read more...
 
First Patient Dosed in Clinical Trial of Halozyme's PEGPH20; Rexahn Reports Interim Clinical Data for Archexin(R) Print E-mail
By Mary Davila   
Thursday, 05 November 2015 20:55
Below is a look at some of the headlines for companies that made news in the healthcare sector on November 5, 2015.   
Read more...
 
MiMedx Issues Document Related to Misinterpretations of FDA's Proposed Draft Guidance; Genocea Presents Positive Findings from ATLASTM Immuno-Oncology Research Collaboration Print E-mail
By Josh Gee   
Wednesday, 04 November 2015 20:35
Below is a look at some of the headlines for companies that made news in the healthcare sector on November 4, 2015.      
Read more...
 
Threshold Pharma Announces Preclinical Data on Combination of Evofosfamide With Immune Checkpoint Inhibitors; Mylan Receives U.S. FTC Clearance for Proposed Acquisition of Perrigo Print E-mail
By Mary Davila   
Tuesday, 03 November 2015 20:53
Below is a look at some of the headlines for companies that made news in the healthcare sector on November 3, 2015.    
Read more...
 
Merck Receives Therapy Designation from FDA for KEYTRUDA(R); Cellectar Provides Phospholipid Drug Conjugate Platform Development Update Print E-mail
By Marilyn Mullen   
Monday, 02 November 2015 20:41
Below is a look at some of the headlines for companies that made news in the healthcare sector on November 2, 2015. 
Read more...
 
Analysts review the Print E-mail
By Marilyn Mullen   
Thursday, 29 October 2015 18:38
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 29, 2015.         
Read more...
 
Gilead Submits NDA to FDA for Fixed-Dose Combination of Sofosbuvir/Velpatasvir; AMAG Pharma Announces 3 Trial Evaluating Feraheme(R) Print E-mail
By Mary Davila   
Wednesday, 28 October 2015 18:52
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 28, 2015.         
Read more...
 
Macrocure Announces Results for Phase III Clinical Trial of CureXcell(R); Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF Phase 2 Print E-mail
By Mary Davila   
Tuesday, 27 October 2015 19:43
Below is a look at some of the headlines for companies that made news in the healthcare sector on October 27, 2015.   
Read more...
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 1 of 369

Newsletter

BioMedReports #Arbutus’ LNP Licensee #Alnylam Announces #FDA Approval of ONPATTRO™ (patisiran), for the

Error. Page cannot be displayed. Please contact your service provider for more details. (13)

Treatment of ATTR Amyloid… https://t.co/SuVNz1uM3i
BioMedReports Why CTI BioPharma Corp. Crashed Today https://t.co/hIobDGpboQ https://t.co/hIobDGpboQ
BMR:1